Fifty years ago, Frances Kelsey revolutionised the regulation of prescription drugs. As a new FDA employee, she reviewed Kevadaon, known as thalidomide. She questioned the drug's safety: "It just came with so many extravagant claims that I didn't believe," she said.
Kelsey took a stance against inadequate testing and corporate pressure, refusing to appr…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.